Last reviewed: November 2017
Last updated: November  2017

Summary

Definition

History and exam

Other diagnostic factors

  • GI symptoms
  • symptom duration >3 months
  • ascites
  • abdominal distention
  • pleural effusion

Risk factors

  • BRCA1 mutation
  • BRCA2 mutation
  • increasing age
  • FHx ovarian cancer
  • FHx breast cancer
  • never used OCP
  • nulliparity
  • obesity
  • hormone therapy
  • Lynch II syndrome

Diagnostic investigations

1st investigations to order

  • pelvic ultrasound
  • CT scan
  • CA-125
  • histopathology
Full details

Investigations to consider

  • PET scan or integrated PET-CT
Full details

Treatment algorithm

Contributors

Authors VIEW ALL

Justin C. Chura

Director

Gynecologic Oncology and Robotic Surgery

Cancer Treatment Centers of America

Eastern Regional Medical Center

Philadelphia

PA

Disclosures

JCC declares that he has no competing interests.

Dr Justin C. Chura would like to gratefully acknowledge Dr Allison E. Axtell, the previous contributor to this monograph. AEA declares that she has no competing interests.

Peer reviewers VIEW ALL

Chairman

Obstetrics and Gynecology

Northeast Ohio Universities of Medicine (NEOMED)

Rootstown

OH

Disclosures

MPH declares that he has no competing interests.

Gynecologic Oncology Fellow

Johns Hopkins Medical Institutions

Baltimore

MD

Disclosures

RS declares that she has no competing interests.

Associate Professor

Chief, Gynecologic Oncology

Department of Obstetrics & Gynecology (UCD)

University of Colorado Cancer Center

Aurora

CO

Disclosures

SAD declares that she has no competing interests.

Consultant Gynaecological Oncologist

Northern Gynaecological Oncology Centre

Queen Elizabeth Hospital

Gateshead

UK

Disclosures

KG is co-author of a systematic review (in print) of follow-up strategies after primary treatment in ovarian cancer. This is not referenced in this monograph.

Use of this content is subject to our disclaimer